Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEX Biometrics ASA Share Issue/Capital Change 2021

Jun 3, 2021

3633_rns_2021-06-03_2b6e890d-04be-46a8-ae58-8494e25487ba.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

IDEX Biometrics: Employee Share Purchase Plan - 3 June 2021

IDEX Biometrics: Employee Share Purchase Plan - 3 June 2021

The board of directors of IDEX Biometrics ASA has resolved to issue 972,642

ordinary shares at NOK 2.08 per share to employees who participate in the

company's Employee Share Purchase Plan (ESPP), which plan was approved by the

annual general meeting on 15 May 2020.

54 employees participated in the ESPP in this period. The participating

employees have elected to invest a part of the base salary in ordinary shares in

the company. Purchase takes place every three months. The shares are restricted

for three months.

Following the issue, the Company's share capital will be NOK 137,734,306.50

divided into 918,228,710 shares each with a nominal value of NOK 0.15.

Primary insiders

IDEX discloses transactions by the following primary insiders in IDEX shares

ISIN NO0003070609:

-   CEO Vince Graziani acquired 19,984 ordinary shares at NOK 2.08 per share.

-   CTO Anthony Eaton acquired 4,363 ordinary shares at NOK 2.08 per share.

IDEX 2020 ESPP

The ESPP was approved at the annual general meeting on 15 May 2020. Reference is

made to the notice of said meeting where the plan document in connection with

the ESPP is attached.

All employees in the Company and its subsidiaries, except in China, have been

offered to subscribe for shares in the Company in connection with the ESPP. The

ESPP is structured around four contribution periods a year, each starting on the

first day of the calendar month following each planned disclosure of an interim

report of the Company and lasts for the following three months. During each

contribution period, a fixed amount (up to 20% of the employee's gross base

salary) is withheld from the employee's net salary. The employee may sign up to

participate in the ESPP from the date of a public disclosure of an interim

report until the beginning of the contribution period. Unless the employee

actively withdraws from the ESPP, participation is automatically renewed for the

same amount for subsequent contribution periods. The board's resolution to issue

new shares in connection with the ESPP is made pursuant to the authorization

granted by the Company's annual general meeting on 15 May 2020 to increase the

Company's share capital in connection with the ESPP.

In accordance with the ESPP, the subscription price is the lower closing price

of the Company's share, as traded on Oslo Børs, on the first or last day of the

contribution period, less 15% discount. Payment of the subscription amount is

made out of the relevant employee salary withholding.

In accordance with Regulation (EU) 2017/1129 (the "Prospectus Regulation")

Article 1 (5) h, issuance of shares in connection with the ESPP is exempt from

the obligation to publish a listing prospectus.

For further information contact:

Marianne Bøe, Investor Relations

E-mail: [email protected]

Tel: + 47 918 00186

Brett L. Perry, U.S. Investor Relations

E-mail: [email protected]

Tel: +1 214 272 0070

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of

fingerprint identification technologies offering simple, secure, and personal

touch-free authentication for all. We help people make payments, prove their

identity, gain access to information, unlock devices, or gain admittance to

buildings. We invent, engineer, and commercialize these secure and safe yet

incredibly user-friendly solutions. Our total addressable market represents a

fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section

5-12 the Norwegian Securities Trading Act